Crinetics Pharmaceuticals, Inc. (CRNX): Price and Financial Metrics
CRNX Price/Volume Stats
| Current price | $56.07 | 52-week high | $62.53 |
| Prev. close | $55.17 | 52-week low | $29.72 |
| Day low | $54.64 | Volume | 493,500 |
| Day high | $56.43 | Avg. volume | 783,210 |
| 50-day MA | $55.20 | Dividend yield | N/A |
| 200-day MA | $48.82 | Market Cap | 5.20B |
CRNX Stock Price Chart Interactive Chart >
Crinetics Pharmaceuticals, Inc. (CRNX) Company Bio
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is CRN00808, an oral selective nonpeptide somatostatin receptor type 2 biased agonist, which is in Phase I clinical trials used for the treatment of acromegaly. The company is also developing CRN02481, an oral selective nonpeptide somatostatin type 5 receptor agonist used for the treatment of congenital hyperinsulinism; and CRN01941, an oral, selective nonpeptide sst2 biased agonist designed for the treatment of neuroendocrine tumors. Crinetics Pharmaceuticals, Inc. was founded in 2008 and is based in San Diego, California.
CRNX Price Returns
| 1-mo | -5.94% |
| 3-mo | 5.49% |
| 6-mo | 18.12% |
| 1-year | 82.40% |
| 3-year | 119.62% |
| 5-year | 200.64% |
| YTD | 57.59% |
| 2023 | 94.43% |
| 2022 | -35.59% |
| 2021 | 101.35% |
| 2020 | -43.76% |
| 2019 | -16.34% |
Continue Researching CRNX
Want to do more research on Crinetics Pharmaceuticals Inc's stock and its price? Try the links below:Crinetics Pharmaceuticals Inc (CRNX) Stock Price | Nasdaq
Crinetics Pharmaceuticals Inc (CRNX) Stock Quote, History and News - Yahoo Finance
Crinetics Pharmaceuticals Inc (CRNX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...